 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
| «12 |
- ||||| H3B-6545 / Eisai
New P1/2 trial, Metastases: H3B-6545-A001-101: Trial of H3B-6545, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast Cancer (clinicaltrials.gov) - Aug 15, 2017
P1/2, N=110, Not yet recruiting, Sponsor: H3 Biomedicine Inc.